AA

14 January 2015
PhEur 8th Edition: 3 monographs will be suppressed on 1 January 2016

The European Pharmacopoeia Commission adopted the recommendation and has set 1 January 2016 as the date on which the monographs on Clostridium novyi alpha antitoxin for veterinary use (0339), Clostridium...

Read more

06 January 2015

Pharmeuropa: Issue 27.1 is complete

Deadline for comments: 31 March 2015

Pharmeuropa contains draft pharmacopoeial texts for which the European Pharmacopoeia Commission is seeking comment. If you would like to receive e-mail alerts when an issue is complete, please register...

Read more

17 December 2014

Human antithrombin III concentrate (0878)

Rapid implementation of corrected monograph

This monograph was corrected in order to include verbatim the Assay of heparin method in chapter 2.7.5 which appeared in the Ph. Eur. prior to supplement 8.3.

 

This correction was made...

Read more

11 December 2014

150th session of the European Pharmacopoeia Commission

The European Pharmacopoeia Commission held its 150th session in Strasbourg on 25-26 November 2014. During the session, the Commission adopted 13 new texts for inclusion in the European Pharmacopoeia, as well as 28 revised...

Read more

26 November 2014
Pharmacopoeial Discussion Group Achievements

The Pharmacopoeial Discussion Group (PDG) [European Pharmacopoeia (EP), Japanese Pharmacopoeia (JP) and United States Pharmacopeia (USP)] met on November 12 and 13, 2014 in Strasbourg, France. At present, 29 of the 36 General Chapters...

Read more

19 November 2014

Launch of the new Standard Terms database

A new version of the Standard Terms database has been launched online, with access available free of charge upon registration.

 

The database has undergone a major revision and reorganisation, allowing greater flexibility in...

Read more

Upcoming events

9-10 July 2015
European Pharmacopoeia Training Session

Strasbourg, France

More information will be available soon

Lire la suite

Additional Information


Previous Press Releases

Disclaimer - Created by 2exVia with MasterEdit®